A new technique aimed at establishing rapidly whether cancer treatments are working has been tested on its first UK patient, it was announced today.
The technique, which monitors glucose uptake, is already under trial in North America.
The study in Cambridge, UK, will be the third worldwide to assess the effectiveness of the metabolic imaging technique.
Developers say it could help doctors assess within a couple of days of treatment starting whether cancer cells are still active.
It uses pyruvate, a break-down product of glucose, labelled with carbon 13. MRI scanning can then monitor its uptake by cancer cells – showing how quickly they break the substance down.
Dr Ferdia Gallagher, from the Cambridge University department of radiology, said: “This new technique could potentially mean that doctors will find out much more quickly if a treatment is working for their patient instead of waiting to see if a tumour shrinks.”
Professor Kevin Brindle, from the Cancer Research UK Cambridge Institute, said: "We hope that it will soon help improve treatment by putting to an end patients being given treatments that aren’t working for them.
"Each person’s cancer is different and this technique could help us tailor a patient’s treatment more quickly than before.”

Leave a Reply